Datasets:
jarrydmartinx
/
support2

Dataset card Data Studio Files
xet
Community
age
float64
18
102
sex
stringclasses
2 values
hospdead
int64
0
1
slos
int64
3
343
dzgroup
stringclasses
8 values
dzclass
stringclasses
4 values
num.co
int64
0
9
edu
float64
0
31
⌀
income
stringclasses
4 values
scoma
float64
0
100
⌀
charges
float64
1.17k
1.44M
⌀
totcst
float64
0
633k
⌀
totmcst
float64
-102.72
711k
⌀
avtisst
float64
1
83
⌀
race
stringclasses
5 values
sps
float64
0.2
99.2
⌀
aps
float64
0
143
⌀
surv2m
float64
0
0.97
⌀
surv6m
float64
0
0.95
⌀
hday
int64
1
148
diabetes
int64
0
1
dementia
int64
0
1
ca
stringclasses
3 values
prg2m
float64
0
1
⌀
prg6m
float64
0
1
⌀
dnr
stringclasses
3 values
dnrday
float64
-88
285
⌀
meanbp
float64
0
195
⌀
wblc
float64
0
200
⌀
hrt
float64
0
300
⌀
resp
float64
0
90
⌀
temp
float64
31.7
41.7
⌀
pafi
float64
12
890
⌀
alb
float64
0.4
29
⌀
bili
float64
0.1
63
⌀
crea
float64
0.1
21.5
⌀
sod
float64
110
181
⌀
ph
float64
6.83
7.77
⌀
glucose
float64
0
1.09k
⌀
bun
float64
1
300
⌀
urine
float64
0
9k
⌀
adlp
float64
0
7
⌀
adls
float64
0
7
⌀
sfdm2
stringclasses
5 values
adlsc
float64
0
7.07
event_times
int64
3
2.03k
event_indicators
int64
0
1
43.23599
male
1
11
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
$25-$50k
0
null
36,952.3438
34,295
46
black
32.59375
53
0.754883
0.67688
1
0
0
no
0.7
0.7
no dnr
11
110
30.398438
80
27
38.69531
56.66406
2.899902
0.899902
2.299805
126
7.5
340
39
740
null
0
<2 mo. follow-up
0
11
1
67.93195
female
0
7
CHF
COPD/CHF/Cirrhosis
2
14
null
0
null
4,060.2891
3,705
4
white
13.699219
28
0.908936
0.8479
1
0
0
no
0.9
0.85
no dnr
7
75
15.798828
110
30
36.19531
264
2.5
0.399963
0.899902
135
7.419922
198
14
1,300
3
3
no(M2 and SIP pres)
3
565
1
65.008
male
0
7
CHF
COPD/CHF/Cirrhosis
3
null
null
0
null
4,747.207
4,657
6.5
white
14.5
14
0.908936
0.846924
1
1
0
no
null
null
no dnr
7
100
14.699219
100
22
36.39844
null
null
0.699951
1.5
125
null
158
16
3,205
null
null
null
2.532227
315
1
73.62097
male
0
13
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$11-$25k
0
25,411
15,708.2734
15,444
15.5
black
24.097656
45
0.774902
0.701904
1
0
0
no
0.75
0.7
no dnr
13
80
4.799805
75
20
39.19531
null
2.799805
0.599976
1.099854
134
null
111
9
1,300
1
0
no(M2 and SIP pres)
0
716
0
67.49097
male
0
28
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
under $11k
0
98,625
55,380.875
55,038
21.25
white
29.796875
40
0.697998
0.606934
1
0
0
no
0.3
0.25
no dnr
28
62
7.699219
110
31
36.89844
276.625
null
1.099854
3.099609
143
7.369141
99
59
2,050
null
0
adl>=4 (>=5 if sur)
0
716
0
70.21198
male
0
48
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$11-$25k
55
102,847
null
null
27.25
white
33.195313
39
0.332947
0.217987
1
0
0
no
null
null
no dnr
48
75
9.398438
64
20
37.5
null
null
0.399963
1.099854
132
null
163
9
null
null
0
adl>=4 (>=5 if sur)
0
716
0
74.40094
female
0
79
COPD
COPD/CHF/Cirrhosis
2
8
null
0
299,345
172,386.5
169,766
41.25
white
38.09375
39
0.302979
0.123993
13
1
0
no
0.75
0.95
dnr after sadm
17
142
28.398438
115
28
36.69531
122.4375
2
0.399963
9.798828
135
7.399414
133
87
97
null
3
SIP>=30
3
80
1
65.42896
female
0
41
ARF/MOSF w/Sepsis
ARF/MOSF
0
11
under $11k
9
103,987
62,892.3125
60,438
28.75
black
31.796875
47
0.567993
0.45697
5
0
0
no
null
null
no dnr
41
58
12.099609
95
14
37.69531
410
null
null
1.099854
132
7.469727
137
24
1,270
null
0
no(M2 and SIP pres)
0
713
0
38.13599
female
0
12
MOSF w/Malig
ARF/MOSF
3
12
$25-$50k
0
35,399
21,580.125
21,693
27.5
white
34.59375
52
0.319946
0.205994
5
0
0
metastatic
0.7
0.3
dnr after sadm
6
67
12.199219
76
24
38.19531
600
2.799805
null
0.799927
131
7.469727
51
3
2,525
1
0
<2 mo. follow-up
0
46
1
73.32196
male
0
4
Lung Cancer
Cancer
1
16
null
0
null
2,548.1387
3,293
15
white
16.296875
18
0.701904
0.415955
1
0
0
metastatic
null
null
no dnr
4
52
10.798828
45
24
36.5
222.84375
2.399902
2.799805
5
130
7.269531
268
89
3,200
0
null
no(M2 and SIP pres)
0.494751
380
1
64.45197
male
0
8
Colon Cancer
Cancer
1
null
null
0
14,340
8,680.0156
7,993
10.5
white
15.398438
10
0.837891
0.645996
1
0
0
metastatic
null
null
no dnr
8
50
13.5
125
35
36.59375
120
null
null
2.599609
127
7.349609
280
48
1,023
null
null
null
2.215332
165
1
67.49896
female
0
24
COPD
COPD/CHF/Cirrhosis
1
11
$11-$25k
0
37,117
23,135.1562
24,473
18
white
24.898438
24
0.763916
0.625
3
0
0
no
null
null
no dnr
24
125
16.898438
115
40
38.09375
226
null
null
2.799805
145
7.469727
133
79
1,540
0
0
no(M2 and SIP pres)
0
711
0
62.20898
male
0
9
COPD
COPD/CHF/Cirrhosis
2
11
under $11k
0
37,356
23,096.7031
22,627
18
white
20.097656
20
0.853882
0.758911
4
0
0
no
0.98
0.95
no dnr
9
68
10.599609
115
35
37.89844
157.125
2.799805
1.199951
2.299805
134
7.239258
306
35
2,394
0
0
no(M2 and SIP pres)
0
601
1
63.95297
male
0
15
CHF
COPD/CHF/Cirrhosis
4
15
>$50k
0
46,614
null
null
21.333328
white
29.597656
43
0.727905
0.574951
1
1
0
no
0.8
0.75
no dnr
15
71
19.597656
60
16
35.5
null
2.299805
0.399963
0.699951
137
null
78
6
2,800
null
1
no(M2 and SIP pres)
1
710
0
53.81799
male
0
44
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
null
0
87,681
51,575.9688
56,810
19.25
white
19.097656
18
0.861938
0.814941
1
0
0
yes
0.9
0.8
no dnr
44
72
11.298828
50
10
35.89844
144
null
0.599976
2.399902
133
7.529297
158
88
1,620
0
0
no(M2 and SIP pres)
0
431
1
72.72797
male
0
20
CHF
COPD/CHF/Cirrhosis
2
8
null
0
35,733
21,160.5781
21,977
27
white
48
63
0.178986
0.049995
1
0
0
no
0.9
0.7
no dnr
20
70
4.699219
75
16
35.59375
null
null
1.199951
1.299805
142
null
140
41
1,880
null
1
null
1
259
1
76.36694
male
0
21
Colon Cancer
Cancer
1
14
null
0
23,314
15,320.5312
13,569
10.333328
white
28.699219
14
0.553955
0.230988
1
0
0
metastatic
0.7
0.5
no dnr
21
112
7.199219
130
16
36
213.3125
2.899902
0.5
0.799927
139
7.40918
165
12
980
null
1
<2 mo. follow-up
1
38
1
66.27795
male
0
13
ARF/MOSF w/Sepsis
ARF/MOSF
2
0
under $11k
9
87,124
49,238.125
51,733
16.5
other
28.296875
45
0.61792
0.512939
13
1
0
no
null
null
no dnr
13
48
9.099609
115
24
35.79688
363.3125
2.199707
3
5.699219
143
7.429688
137
51
23
null
2
adl>=4 (>=5 if sur)
2
128
1
82.70996
female
0
20
ARF/MOSF w/Sepsis
ARF/MOSF
2
14
>$50k
0
81,507
50,401.25
48,716
34.333313
white
28.5
40
0.493958
0.376953
1
0
0
metastatic
0.2
0.1
no dnr
20
160
19
55
16
38.19531
210
null
null
1.099854
142
7.489258
185
14
3,480
null
7
<2 mo. follow-up
7
30
1
63.76999
male
0
7
Lung Cancer
Cancer
1
null
null
0
10,343
6,567.582
6,025
9.5
white
24.597656
14
0.532959
0.209991
1
0
0
metastatic
0.5
0.1
no dnr
7
85
6.299805
75
20
36.19531
null
2.399902
0.799927
1.299805
140
null
72
29
null
null
null
null
3.005371
150
1
51.58698
male
0
41
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
under $11k
9
80,835
52,924.9062
52,753
19.75
black
31.296875
75
0.691895
0.599976
2
1
0
no
0.7
0.7
no dnr
41
118
4.799805
125
10
36.19531
260
4
0.699951
0.799927
137
7.40918
121
11
3,730
null
1
SIP>=30
1
707
0
75.82495
female
0
10
MOSF w/Malig
ARF/MOSF
2
null
under $11k
0
33,451
20,574.2031
20,619
23.5
black
24.097656
26
0.517944
0.401978
11
1
0
metastatic
0.1
0.1
dnr after sadm
6
118
0.099991
135
25
38.19531
200
2.099609
0.699951
3
133
7.359375
248
124
1,805
null
6
<2 mo. follow-up
6
14
1
69.66498
male
1
19
Coma
Coma
0
0
null
37
70,791
42,966.5312
41,661
25.666656
black
29.796875
62
0.311951
0.240997
1
0
0
no
0.6
0.6
dnr after sadm
18
108
14.798828
70
18
36.79688
308
null
0.599976
0.899902
137
7.469727
280
27
null
null
0
<2 mo. follow-up
0
19
1
82.69995
male
1
30
ARF/MOSF w/Sepsis
ARF/MOSF
2
9
$11-$25k
9
44,008
28,144.6562
28,474
13.5
white
19.398438
40
0.748901
0.669922
5
0
0
no
null
null
dnr after sadm
3
110
8.099609
100
22
36.29688
347.5625
null
0.399963
0.899902
135
7.469727
92
6
null
null
6
<2 mo. follow-up
6
30
1
58.19299
male
1
6
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
0
25,996
15,017.2188
15,660
14
white
31.199219
30
0.504883
0.387939
6
0
0
metastatic
0.4
0.1
dnr after sadm
5
73
6.899414
120
27
38.59375
161.65625
null
0.699951
1.699951
136
7.5
172
30
3,165
null
null
<2 mo. follow-up
2.782715
6
1
33.78
female
0
15
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$11-$25k
0
41,677
25,193.125
23,917
28
white
29.796875
42
0.828979
0.770996
1
0
0
no
0.8
0.8
no dnr
15
58
3.399902
110
10
36.09375
126
null
2.5
0.799927
146
7.469727
217
25
3,120
null
null
no(M2 and SIP pres)
2.071777
705
0
47.93198
female
0
22
ARF/MOSF w/Sepsis
ARF/MOSF
1
13
null
0
58,215
null
null
23
black
23.597656
39
0.832886
0.776978
5
1
0
no
0.9
0.9
no dnr
22
75
17.898438
115
10
36.09375
148.875
2.199707
null
0.699951
136
7.509766
157
36
3,065
0
null
null
0.494751
705
0
48.375
male
0
8
MOSF w/Malig
ARF/MOSF
2
9
under $11k
9
19,396
11,940.75
11,809
21
white
21.296875
22
0.681885
0.588989
1
0
0
metastatic
0.25
0.05
dnr after sadm
5
78
5
65
16
36.39844
214.28125
null
0.5
1.799805
136
7.439453
178
48
2,050
null
0
<2 mo. follow-up
0
50
1
65.37396
female
1
61
COPD
COPD/CHF/Cirrhosis
1
12
>$50k
0
413,887
246,825.125
253,225
29
white
26
43
0.698975
0.534912
105
0
0
no
0.4
0.4
dnr after sadm
59
132
11.898438
55
10
34.19531
270
1.599854
1.199951
1.299805
136
7.289062
240
17
null
null
2
null
2
61
1
64.53699
male
0
9
COPD
COPD/CHF/Cirrhosis
1
7
$25-$50k
0
11,580
7,392.9297
7,688
12.5
white
21.597656
39
0.848999
0.751953
1
0
0
no
1
1
no dnr
9
97
7.899414
80
28
36.79688
247.59375
null
null
0.5
139
7.479492
185
11
900
0
0
no(M2 and SIP pres)
0
703
0
57.46198
male
0
27
COPD
COPD/CHF/Cirrhosis
3
18
$25-$50k
0
21,367
15,081.9297
19,774
7.25
white
14.298828
13
0.931885
0.883911
1
1
0
no
null
null
dnr after sadm
1
86
11.599609
88
22
37
256
3.399902
0.5
1.299805
143
7.369141
147
22
2,000
6
null
no(M2 and SIP pres)
4.527344
703
0
47.69598
male
1
5
MOSF w/Malig
ARF/MOSF
1
12
$25-$50k
0
32,557
18,351.9062
17,679
52
black
45.796875
75
0.144989
0.068985
1
0
0
yes
0.4
0.35
dnr after sadm
5
142
0.199982
115
25
39.39844
120
2.299805
1.399902
0.599976
129
7.439453
201
13
5,630
null
2
<2 mo. follow-up
2
5
1
56.60199
female
1
7
Cirrhosis
COPD/CHF/Cirrhosis
3
null
null
26
18,544
11,228.7109
10,687
9.5
black
34.796875
38
0.329956
0.144989
2
0
0
no
0.5
0.4
dnr after sadm
7
122
9.699219
115
12
38.19531
187.5
2.899902
2.799805
1.199951
137
7.459961
83
16
4,150
null
0
<2 mo. follow-up
0
7
1
66.41998
male
0
68
ARF/MOSF w/Sepsis
ARF/MOSF
2
9
under $11k
0
236,103
136,933.75
146,712
40.25
white
27.898438
53
0.689941
0.5979
5
1
0
no
0.8
0.8
no dnr
68
65
7.799805
65
33
37.69531
232.5
null
null
0.899902
138
7.509766
110
20
850
null
0
no(M2 and SIP pres)
0
702
0
23.55099
female
0
104
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
$25-$50k
0
433,851
245,377.875
254,332
39.25
white
32.898438
43
0.779907
0.708984
6
1
0
no
0.6
0.6
no dnr
104
122
17.898438
115
31
36.5
208.5625
3.299805
null
1.099854
133
7.489258
248
23
2,230
null
5
adl>=4 (>=5 if sur)
5
702
0
57.74698
female
1
7
ARF/MOSF w/Sepsis
ARF/MOSF
0
10
$11-$25k
0
89,650
50,894.0938
50,447
43.5
white
32.796875
36
0.587891
0.478943
18
0
0
no
0.5
0.5
dnr after sadm
7
107
13.898438
135
39
37.69531
246.65625
null
8
2.099609
150
7.439453
115
31
3,610
null
0
<2 mo. follow-up
0
7
1
62.508
male
1
10
ARF/MOSF w/Sepsis
ARF/MOSF
0
17
null
0
58,969
34,627.7812
37,208
42.5
white
32
53
0.655884
0.556885
2
0
0
no
0.6
0.4
dnr after sadm
10
72
3.599609
79
32
36.79688
265
2.199707
null
0.899902
140
7.279297
69
14
2,950
null
0
<2 mo. follow-up
0
10
1
76.97998
male
1
35
ARF/MOSF w/Sepsis
ARF/MOSF
1
21
>$50k
0
236,578
131,075.25
116,139
46.75
white
42
65
0.130981
0.059998
14
0
0
yes
null
null
dnr after sadm
16
127
7
105
0
38.39844
188.875
null
null
1.699951
142
7.449219
183
38
2,550
null
5
<2 mo. follow-up
5
35
1
79.59796
male
0
12
ARF/MOSF w/Sepsis
ARF/MOSF
2
5
under $11k
9
25,694
18,034.7812
17,946
17
black
26
49
0.68396
0.590942
1
1
0
no
0.7
0.6
no dnr
12
115
7
130
16
37.89844
316
null
null
0.799927
139
7.459961
136
10
2,350
null
0
no(M2 and SIP pres)
0
700
0
75.63599
female
0
61
ARF/MOSF w/Sepsis
ARF/MOSF
0
14
null
37
140,074
87,156.75
86,931
34
white
27.199219
49
0.560913
0.448975
1
0
0
no
0.6
0.55
dnr after sadm
31
53
10.898438
105
12
37
162.5
null
null
1.299805
125
7.459961
96
25
1,650
null
0
SIP>=30
0
699
0
62.84998
male
1
4
CHF
COPD/CHF/Cirrhosis
6
16
$25-$50k
100
9,831
6,922.8008
6,586
35
black
99.1875
108
0
0
1
1
0
no
null
null
no dnr
4
105
22.097656
65
20
36
376
3.599609
0.699951
2.099609
136
7.439453
161
57
2,050
null
0
<2 mo. follow-up
0
4
1
75.65198
female
1
7
Colon Cancer
Cancer
1
null
null
26
7,277
4,784.5391
4,951
8.5
white
25.898438
41
0.507935
0.186981
1
0
0
metastatic
0.2
0.1
dnr after sadm
1
72
15.898438
55
14
36.19531
219.03125
null
0.699951
0.699951
138
7.399414
126
14
2,580
null
4
<2 mo. follow-up
4
7
1
44.97498
female
0
4
Colon Cancer
Cancer
1
12
$25-$50k
0
6,834
4,132.0703
3,226
1
white
14.699219
9
0.873901
0.716919
1
0
0
metastatic
0.85
0.6
no dnr
4
146
17.898438
120
10
38.5
98.5625
null
null
0.799927
153
7.449219
105
26
3,635
null
null
no(M2 and SIP pres)
2.183594
245
1
70.71899
male
0
4
Lung Cancer
Cancer
1
13
under $11k
0
3,052
null
null
7
white
12.398438
2
0.777954
0.535889
1
0
0
metastatic
0.65
0.25
no dnr
4
80
9.199219
75
20
35.19531
330
null
null
1.799805
140
7.589844
75
41
925
null
0
no(M2 and SIP pres)
0
301
1
64.55896
male
0
13
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
0
53,126
30,766.7812
34,528
41.5
other
24.597656
21
0.775879
0.702881
3
1
0
no
0.7
0.6
no dnr
13
67
12.398438
120
22
38
null
null
null
0.699951
131
null
149
5
1,750
null
3
no(M2 and SIP pres)
3
696
0
69.36597
male
0
19
ARF/MOSF w/Sepsis
ARF/MOSF
2
0
under $11k
0
41,611
23,837.875
24,459
19.666656
white
23.296875
40
0.777954
0.705933
3
0
0
no
0.4
0.3
dnr before sadm
-2
112
15.599609
125
14
38.79688
137.5
2.399902
0.799927
0.599976
136
7.449219
113
20
2,555
null
null
SIP>=30
2.86084
469
1
75.23895
male
0
6
CHF
COPD/CHF/Cirrhosis
2
13
$25-$50k
0
5,511
4,134.3594
3,908
12
white
16.199219
32
0.871948
0.786987
1
0
0
no
null
null
no dnr
6
105
14.5
95
12
38.5
246.65625
3.399902
7
0.899902
135
7.439453
107
11
3,170
0
null
<2 mo. follow-up
0.494751
58
1
68.62695
male
0
54
ARF/MOSF w/Sepsis
ARF/MOSF
1
10
under $11k
9
135,769
null
null
32.5
black
20.398438
13
0.787964
0.718994
5
1
0
no
0.75
0.5
dnr after sadm
1
70
13.298828
120
32
39.29688
151.65625
null
null
2.899902
142
7.419922
115
42
1,960
null
null
adl>=4 (>=5 if sur)
2.023438
117
1
44.172
male
0
21
Lung Cancer
Cancer
4
12
null
0
19,222
12,926.8438
13,219
7.333332
black
23
34
0.630981
0.31897
1
0
0
metastatic
0.2
0.05
dnr after sadm
2
67
5.399414
82
16
36
357.125
4.199219
2.199707
0.899902
133
7.479492
105
23
2,400
0
null
<2 mo. follow-up
0.494751
24
1
39.81699
male
0
20
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
under $11k
41
55,934
34,209.9375
32,849
28.666656
black
32.398438
64
0.626953
0.523926
1
0
0
no
0.3
0.15
no dnr
20
110
8.199219
80
20
37
404.75
3.299805
1.199951
1.099854
139
7.469727
81
21
2,300
null
null
null
2.771973
64
1
80.35895
male
0
19
Lung Cancer
Cancer
1
6
under $11k
26
16,602
11,312.6719
14,701
9.333328
black
24.296875
29
0.350952
0.074997
1
0
0
metastatic
0.3
0.5
dnr after sadm
3
130
35.398438
125
28
36.29688
356
4
null
0.899902
139
7.369141
110
22
620
null
2
<2 mo. follow-up
2
28
1
61.92999
male
1
20
ARF/MOSF w/Sepsis
ARF/MOSF
3
13
under $11k
61
139,557
79,442
81,775
37.333313
white
22
61
0.571899
0.460999
12
1
0
no
0.4
0.15
dnr after sadm
7
78
15.798828
105
11
36.79688
170
null
2.099609
3.099609
137
7.40918
100
58
3,470
null
0
<2 mo. follow-up
0
20
1
71.35895
male
0
10
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
9
55,359
32,655.5
34,134
21
white
25.898438
26
0.646973
0.546997
12
0
0
no
0.95
0.93
no dnr
10
60
14.398438
135
24
38.09375
112.23438
null
0.5
0.799927
125
7.549805
193
28
1,050
null
null
null
2.520508
691
0
74.37396
female
1
18
COPD
COPD/CHF/Cirrhosis
2
null
under $11k
0
24,211
null
null
13
white
23.5
31
0.765991
0.62793
1
1
0
no
0.6
0.4
dnr after sadm
8
138
17.398438
0
38
38
260.8125
3
1.199951
0.5
143
7.239258
268
14
2,797
null
2
<2 mo. follow-up
2
18
1
50.14398
male
0
13
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
under $11k
0
37,721
22,164.2344
21,922
26.5
white
22.097656
30
0.861938
0.813965
2
1
0
no
0.5
0.45
no dnr
13
60
6.099609
125
13
38.79688
158
null
5.299805
1.399902
149
7.379883
283
16
3,430
1
0
SIP>=30
0
691
0
69.67798
male
0
28
ARF/MOSF w/Sepsis
ARF/MOSF
2
14
$11-$25k
100
42,808
26,644.5
26,009
13
white
23.296875
47
0.305969
0.19397
1
0
0
yes
0.7
0.6
dnr after sadm
7
113
3.5
125
35
36.19531
185.6875
null
1.799805
2.199707
140
7.389648
149
33
1,225
null
7
adl>=4 (>=5 if sur)
7
77
1
76.62695
male
0
7
Colon Cancer
Cancer
1
19
null
0
13,251
7,951.0664
7,827
7.5
white
22.398438
16
0.700928
0.414978
1
0
0
metastatic
0.85
0.6
no dnr
7
63
4.699219
79
28
38
null
3.299805
null
1
135
null
88
9
null
null
null
no(M2 and SIP pres)
1.975342
691
0
24.02199
female
1
18
Cirrhosis
COPD/CHF/Cirrhosis
2
12
null
44
101,207
null
null
42.666657
black
39.296875
61
0.459961
0.258972
2
0
0
no
0.15
0.05
dnr after sadm
16
100
null
65
20
36.09375
null
null
0.699951
1
139
null
88
6
1,590
null
0
<2 mo. follow-up
0
18
1
37.34198
male
1
9
ARF/MOSF w/Sepsis
ARF/MOSF
4
10
under $11k
44
34,273
19,557.6719
17,295
41.5
black
48.898438
100
0.167999
0.084991
1
0
0
no
0.25
0.1
dnr after sadm
8
115
14.898438
105
24
35.59375
284
3.199707
0.5
0.699951
149
7.449219
125
21
655
null
0
<2 mo. follow-up
0
9
1
76.23798
male
1
27
COPD
COPD/CHF/Cirrhosis
6
3
null
0
69,596
42,462.75
45,356
21
white
23.898438
38
0.669922
0.497986
13
1
0
no
0.5
0.5
dnr after sadm
11
98
10.398438
95
24
36.89844
223.3125
3.099609
1.299805
1.5
139
7.359375
94
31
2,760
null
6
<2 mo. follow-up
6
27
1
73.36597
male
0
8
COPD
COPD/CHF/Cirrhosis
2
14
under $11k
0
7,477
5,118.168
5,491
12.5
black
19.699219
24
0.826904
0.717896
1
0
0
no
0.9
0.9
no dnr
8
118
10.798828
145
10
38.09375
205.6875
null
0.599976
2.199707
126
7.389648
199
62
3,510
null
1
no(M2 and SIP pres)
1
690
0
66.75696
male
0
4
Lung Cancer
Cancer
2
14
$25-$50k
0
4,269
2,855.1348
2,803
9
black
14.898438
14
0.743896
0.480957
1
1
0
metastatic
0.6
0.2
no dnr
4
107
79.390625
88
20
37.69531
205.6875
3.299805
0.799927
1.699951
140
7.429688
97
13
3,370
null
null
<2 mo. follow-up
2.84668
52
1
62.15698
female
0
28
ARF/MOSF w/Sepsis
ARF/MOSF
1
14
null
0
77,908
45,678.2188
43,515
25.5
white
23.398438
32
0.755981
0.677979
3
0
0
yes
0.7
0.65
no dnr
28
43
27.199219
0
12
38
164
3.699707
1
1.899902
126
7.319336
297
30
1,650
null
0
no(M2 and SIP pres)
0
690
0
81.57697
male
1
20
Lung Cancer
Cancer
1
16
$25-$50k
0
25,226
15,696.3906
16,137
9.666664
white
16.796875
26
0.670898
0.371948
1
0
0
metastatic
0.5
0.3
dnr after sadm
11
117
12.298828
97
20
35.29688
null
2.799805
1.5
1
136
null
98
18
1,600
null
0
<2 mo. follow-up
0
20
1
76.271
male
0
14
COPD
COPD/CHF/Cirrhosis
1
13
under $11k
9
37,912
21,666.0156
22,946
20.333328
white
25.5
24
0.681885
0.512939
1
0
0
no
0.6
0.6
no dnr
14
65
10.099609
65
24
34.69531
388
null
null
1.899902
127
7.459961
211
50
930
0
3
no(M2 and SIP pres)
3
688
0
45.17697
male
0
16
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
under $11k
0
61,094
null
null
16.666656
black
22.5
42
0.850952
0.79895
6
0
0
no
0.9
0.9
no dnr
16
59
10.398438
130
12
36.59375
160
2.099609
null
0.399963
137
7.40918
134
13
1,585
0
0
no(M2 and SIP pres)
0
686
0
81.74695
female
0
18
COPD
COPD/CHF/Cirrhosis
2
14
null
9
20,315
13,006.9844
14,392
12.666664
white
26.097656
22
0.61499
0.427979
1
0
0
no
null
null
dnr after sadm
2
113
10.798828
117
24
36.29688
null
3.099609
0.399963
1.099854
136
null
113
15
null
0
1
adl>=4 (>=5 if sur)
1
311
1
68.70099
male
0
5
Lung Cancer
Cancer
1
11
$25-$50k
0
8,034
4,381.0547
2,749
10
white
25.597656
22
0.487976
0.168976
1
0
0
metastatic
0.8
0.3
no dnr
5
127
21.199219
65
27
34.5
155
2.799805
null
12.298828
132
7.289062
318
97
0
0
0
no(M2 and SIP pres)
0
161
1
40.323
male
0
6
Cirrhosis
COPD/CHF/Cirrhosis
3
12
under $11k
0
6,150
null
null
9
white
13.099609
23
0.928955
0.878906
1
0
0
no
0.99
0.95
no dnr
6
115
18.5
110
27
36.19531
192.5
2.199707
0.5
1.299805
142
7.399414
89
15
3,545
0
1
no(M2 and SIP pres)
1
685
0
54.87997
male
1
8
CHF
COPD/CHF/Cirrhosis
4
10
under $11k
0
9,508
6,299.5547
6,980
13
black
26.398438
42
0.817993
0.704956
1
1
0
no
0.4
0.25
dnr after sadm
2
120
19.5
155
40
35.39844
300
2.5
1.599854
1.599854
135
7.439453
244
43
1,875
null
5
<2 mo. follow-up
5
8
1
67.85999
male
0
35
COPD
COPD/CHF/Cirrhosis
1
12
under $11k
0
41,179
26,610.875
28,870
13.25
white
23.097656
41
0.813965
0.697998
1
0
0
no
0.6
0.5
dnr after sadm
23
73
9.898438
70
28
36
260
null
null
1.5
137
7.389648
88
53
1,100
null
6
<2 mo. follow-up
6
54
1
62.73499
male
0
10
Colon Cancer
Cancer
1
12
$11-$25k
0
24,370
14,301.3906
13,667
23.5
white
29.5
36
0.580933
0.260986
1
0
0
metastatic
0.85
0.6
no dnr
10
113
30.898438
110
22
35.5
175
3.099609
0.799927
0.5
130
7.429688
223
14
1,510
0
0
no(M2 and SIP pres)
0
684
0
33.59299
female
0
35
Coma
Coma
0
14
$11-$25k
89
141,781
79,643
77,889
43.5
black
25.699219
29
0.472961
0.399963
4
0
0
no
0.8
0.75
no dnr
35
105
3.399902
110
33
35.19531
192.5
2.199707
1.099854
0.899902
144
7.419922
535
12
1,840
null
0
adl>=4 (>=5 if sur)
0
683
0
67.849
male
0
18
Colon Cancer
Cancer
3
13
$11-$25k
0
42,241
25,081.6094
24,191
20.333328
white
13.5
16
0.853882
0.67688
1
0
0
metastatic
null
null
no dnr
18
75
19.597656
125
28
37.69531
360
1.599854
1
1.699951
143
7.399414
62
18
2,940
0
0
no(M2 and SIP pres)
0
683
0
75.98395
male
1
14
ARF/MOSF w/Sepsis
ARF/MOSF
1
10
under $11k
9
124,688
69,735.1875
66,838
36
white
32.195313
57
0.454956
0.335999
11
0
0
no
0.5
0.5
dnr after sadm
14
128
7
115
10
38
266.625
2.5
0.5
0.599976
130
7.379883
125
8
1,570
null
0
<2 mo. follow-up
0
14
1
59.98898
male
1
4
Coma
Coma
0
null
null
100
19,554
11,011.9375
10,200
32
white
47.695313
79
0
0
1
0
0
no
null
null
dnr after sadm
3
148
13.099609
125
40
36.29688
240
null
0.5
0.5
140
7.399414
166
36
1,920
null
null
<2 mo. follow-up
2.384766
4
1
66.16296
female
0
5
Lung Cancer
Cancer
1
12
$25-$50k
0
3,425
2,377.1035
2,767
8
white
32
21
0.30896
0.053993
1
0
0
metastatic
null
null
no dnr
5
100
8.199219
112
24
36.29688
191.28125
null
null
1.299805
136
7.349609
78
24
1,850
1
null
<2 mo. follow-up
1.166748
23
1
54.34598
male
1
4
MOSF w/Malig
ARF/MOSF
1
12
under $11k
0
39,155
22,249.7188
23,339
41
white
46.796875
85
0.060997
0.021
8
0
0
yes
0.01
0.01
dnr after sadm
1
120
5.399414
84
24
36.59375
216
null
null
1
139
7.429688
95
10
null
null
null
<2 mo. follow-up
1.947022
4
1
51.129
male
0
29
ARF/MOSF w/Sepsis
ARF/MOSF
0
11
under $11k
0
131,464
74,448
71,239
37
hispanic
35.398438
72
0.612915
0.506958
4
0
0
no
0.5
0.5
no dnr
29
50
7.5
140
20
41.19531
62
2.799805
1.099854
4.599609
149
7.419922
269
73
1,320
null
null
null
2.016113
680
0
71.69897
male
1
13
ARF/MOSF w/Sepsis
ARF/MOSF
3
6
under $11k
0
107,816
61,209.9062
60,001
35
white
32.796875
50
0.427979
0.307983
11
0
0
yes
null
null
dnr after sadm
11
72
22.199219
105
24
35
300
null
21.898438
1.699951
142
7.399414
109
15
null
null
3
<2 mo. follow-up
3
13
1
38.905
female
0
15
ARF/MOSF w/Sepsis
ARF/MOSF
0
15
$25-$50k
0
98,683
53,027.2812
63,449
13.666664
white
26.796875
55
0.809937
0.745972
8
0
0
no
null
null
no dnr
15
103
12
145
42
39
236.65625
null
null
1.399902
160
7.459961
378
36
1,955
0
0
no(M2 and SIP pres)
0
679
0
71.43896
female
0
12
Lung Cancer
Cancer
1
4
$11-$25k
0
12,884
8,372.8438
8,295
6.5
white
25.597656
16
0.478943
0.161987
1
0
0
metastatic
0.3
0.1
no dnr
12
68
16.398438
135
36
39.59375
122.21875
3.099609
1
0.599976
134
7.509766
78
21
2,210
4
5
<2 mo. follow-up
5
47
1
71.625
female
1
24
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
0
126,801
70,188.5625
76,054
42
white
21.796875
72
0.770996
0.697998
7
0
0
no
0.3
0.15
dnr after sadm
16
63
45.5
115
22
37.79688
100
2.5
4.399414
0.799927
151
7.339844
62
9
4,270
null
6
<2 mo. follow-up
6
24
1
55.79999
female
0
12
Lung Cancer
Cancer
1
15
null
0
11,030
7,579.8672
8,021
8
white
15.5
13
0.755981
0.500977
1
0
0
metastatic
0.7
0.3
no dnr
12
103
1.099854
75
29
36.5
196.65625
2.5
5.199219
1.799805
142
7.489258
174
41
1,070
1
2
null
2
63
1
33.405
male
1
4
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
26
198,996
130,510.75
157,130
55
white
59.695313
114
0.016998
0.004
10
0
0
no
null
null
dnr after sadm
4
53
23.097656
120
12
39.29688
138.4375
3.399902
5
3.899902
146
7.479492
88
79
1,545
null
null
<2 mo. follow-up
1.804443
4
1
43.25
male
1
14
ARF/MOSF w/Sepsis
ARF/MOSF
0
8
under $11k
0
133,810
72,628.0625
63,859
53.333313
white
28.699219
66
0.800903
0.734985
2
0
0
no
0.5
0.5
dnr after sadm
12
133
8.5
115
33
39.39844
259.25
3.199707
1.599854
2.899902
145
7.479492
212
81
2,215
null
5
<2 mo. follow-up
5
14
1
38.68298
female
0
6
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
0
17,416
11,765.0156
12,120
20
black
20
16
0.910889
0.878906
1
1
0
no
0.8
0.8
no dnr
6
132
13.199219
140
26
38.29688
131.09375
null
0.699951
0.899902
143
7.459961
331
28
4,210
0
1
no(M2 and SIP pres)
1
676
0
48.04099
male
0
7
ARF/MOSF w/Sepsis
ARF/MOSF
2
13
null
0
21,921
12,741.7891
12,294
21.5
white
18.597656
23
0.897949
0.861938
2
0
0
no
0.8
0.75
no dnr
7
0
11.798828
0
0
36.39844
31
1
0.799927
2
136
7.239258
267
48
1,415
0
0
no(M2 and SIP pres)
0
253
1
69.64294
female
0
15
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
under $11k
0
58,826
32,107.7812
37,998
20
white
21.5
39
0.803955
0.738892
3
1
1
no
0.95
0.93
no dnr
15
53
9.599609
96
20
34.29688
340
null
null
0.899902
140
7.429688
65
10
220
null
3
adl>=4 (>=5 if sur)
3
674
0
77.57397
female
0
13
ARF/MOSF w/Sepsis
ARF/MOSF
1
7
under $11k
0
53,539
30,638.8281
34,531
24.5
white
29.597656
37
0.62793
0.524902
2
1
0
no
0.95
0.94
no dnr
13
105
7.899414
80
20
36.79688
null
null
0.199982
0.599976
142
null
101
11
null
1
0
adl>=4 (>=5 if sur)
0
674
0
70.34399
male
0
5
ARF/MOSF w/Sepsis
ARF/MOSF
3
5
under $11k
37
10,496
6,644.6328
6,839
18
black
19.898438
36
0.747925
0.668945
1
1
1
no
null
null
no dnr
5
96
10.898438
76
18
36.79688
428.5625
3.699707
0.799927
0.899902
140
7.459961
91
8
null
null
null
adl>=4 (>=5 if sur)
5.283203
128
1
59.37
female
1
17
Coma
Coma
0
null
null
89
58,477
35,668.375
32,849
35.666657
black
21.398438
25
0.393982
0.319946
1
0
0
no
0.2
0.2
dnr after sadm
17
105
9.398438
105
33
36.29688
175
null
null
1.199951
132
7.439453
251
13
3,130
null
null
<2 mo. follow-up
2.172363
17
1
54.94897
female
0
46
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
under $11k
0
174,126
null
null
25.75
black
18.199219
10
0.853882
0.803955
26
0
1
no
0.9
0.5
no dnr
46
68
20.898438
125
12
37.39844
184
2.099609
0.199982
0.699951
142
7.389648
89
17
795
null
1
adl>=4 (>=5 if sur)
1
672
0
68.99896
male
0
7
CHF
COPD/CHF/Cirrhosis
3
12
null
0
19,868
11,311.4609
10,106
20
white
18.796875
18
0.862915
0.773926
1
0
0
no
0.95
0.92
no dnr
7
70
11.5
85
20
36
247.59375
4.099609
1.699951
1.699951
138
7.509766
97
25
1,810
null
0
no(M2 and SIP pres)
0
134
1
71.96399
female
1
31
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
0
256,844
137,596.625
120,536
44.25
white
33.796875
53
0.469971
0.350952
16
0
0
no
null
null
dnr after sadm
28
113
11.798828
55
30
38.5
353.3125
null
null
0.599976
136
7.449219
158
11
2,670
null
null
<2 mo. follow-up
2.034668
31
1
47.35098
male
0
5
Lung Cancer
Cancer
1
12
null
0
3,470
2,491.9434
2,469
4
white
19.898438
13
0.690918
0.40094
1
0
0
metastatic
0.3
0.1
no dnr
5
74
11.398438
126
24
38.39844
304
null
0.799927
0.899902
128
7.429688
80
26
825
1
2
no(M2 and SIP pres)
2
339
1
69.92499
female
0
8
COPD
COPD/CHF/Cirrhosis
1
18
>$50k
0
8,151
5,344.1797
6,379
5.5
white
15.5
23
0.886963
0.810913
1
0
0
no
0.9
0.8
no dnr
8
57
4.099609
115
40
35.59375
192.71875
2.099609
0.799927
1.299805
148
7.479492
82
21
4,140
0
0
no(M2 and SIP pres)
0
671
0
33.577
female
0
10
MOSF w/Malig
ARF/MOSF
1
13
$25-$50k
0
50,575
29,621.375
30,226
33.5
black
36.898438
60
0.326965
0.211975
8
0
0
yes
0.75
0.5
no dnr
10
130
8.898438
64
22
35.59375
null
3.099609
0.799927
1.599854
134
null
129
34
null
null
0
no(M2 and SIP pres)
0
671
0
27.392
female
0
24
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
$11-$25k
26
54,847
34,702.4688
33,386
28
white
27.796875
39
0.815918
0.753906
1
0
0
no
0.8
0.8
no dnr
24
70
7.699219
80
28
36.69531
154
1.799805
1.099854
2
138
7.399414
303
51
2,825
0
0
no(M2 and SIP pres)
0
671
0
55.715
female
0
12
Lung Cancer
Cancer
1
12
null
0
13,445
9,268.0547
10,704
12
white
18.597656
32
0.698975
0.411987
1
0
0
metastatic
0.8
0.6
no dnr
12
72
17.199219
115
28
36.59375
217.125
null
0.699951
0.899902
129
7.489258
102
8
2,750
null
1
no(M2 and SIP pres)
1
211
1